← back to search

Wei Guo

Tsinghua University · CN
🔎 Find collaborators in Molecular Biology · Hepatology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Hepatology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, RNA modifications and cancer, RNA Research and Splicing, and Epigenetics and DNA Methylation.
h-index
21
citations
1,801
works
104
NIH funding
primary concept
Medicine
email

Recent publications

Integrative proteomic profiling of tumor and plasma extracellular vesicles identifies a diagnostic biomarker panel for colorectal cancer
Cell Reports Medicine 2025cited by 15position: middledoi
PCSK9 Targeted Autophagosome-Tethering Compounds: Design, Synthesis, and Antiatherosclerosis Evaluation
Journal of Medicinal Chemistry 2025cited by 6position: middledoi
Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy
Frontiers in Oncology 2025cited by 2position: middledoi
Prediction of the effect of Bupleurum chinensis DC. (Chaihu) on survival and its potential targets in hepatocellular carcinoma based on a prognostic model
BMC Complementary Medicine and Therapies 2025cited by 0position: middledoi
Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT
Hepatology 2024cited by 65position: lastdoi
Next-Generation Patient-Based Real-Time Quality Control Models
Annals of Laboratory Medicine 2024cited by 19position: middledoi
Discovery of autophagy-tethering compounds as potent NLRP3 degraders for IBD Immunotherapy
European Journal of Medicinal Chemistry 2024cited by 13position: middledoi
Design, Synthesis, and Bioevaluation of Novel NLRP3 Inhibitor with IBD Immunotherapy from the Virtual Screen
Journal of Medicinal Chemistry 2024cited by 11position: middledoi
Targeted Degradation of PCSK9 In Vivo by Autophagy-Tethering Compounds
Journal of Medicinal Chemistry 2023cited by 24position: middledoi
Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10
Oxidative Medicine and Cellular Longevity 2022cited by 40position: middledoi
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Nature Communications 2021cited by 213position: middledoi
A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer
Gastroenterology 2021cited by 64position: middledoi
Real-Time Monitoring Renal Impairment Due to Drug-Induced AKI and Diabetes-Caused CKD Using an NAG-Activatable NIR-II Nanoprobe
Analytical Chemistry 2021cited by 43position: middledoi
Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
Cell Death and Disease 2020cited by 141position: middledoi
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single‐center, retrospective, propensity‐matched study
Clinical and Translational Medicine 2020cited by 43position: middledoi
Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma
EBioMedicine 2020cited by 43position: middledoi
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection
Cancer Cytopathology 2020cited by 31position: middledoi
Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target
BMC Cancer 2019cited by 114position: middledoi
Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification
International Journal of Cancer 2019cited by 57position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jia Fan · China Medical University7 papers (2019–2024)Yun‐Fan Sun · Zhongshan Hospital7 papers (2019–2024)Jian Zhou · Shenzhen University Health Science Center6 papers (2019–2024)Bo Hu · Northwestern University6 papers (2019–2020)Xin‐Rong Yang · Sun Yat-sen University6 papers (2019–2024)Pengxiang Wang · Harbin Institute of Technology5 papers (2020–2025)Xianfeng Gu · Fudan University5 papers (2021–2025)Ziwen Zhang · Fudan University4 papers (2023–2025)Kaiqian Zhou · Fudan University4 papers (2020–2020)Jianwen Cheng · Fudan University4 papers (2020–2025)Beili Wang · Sun Yat-sen University4 papers (2019–2024)Hongyu Wu · Fudan University3 papers (2024–2025)Zhonglian Cao · Fudan University3 papers (2024–2025)Yongxing Xue · Fudan University3 papers (2023–2025)Kai Yin · Fudan University3 papers (2021–2024)Zhirong Ouyang · Fudan University3 papers (2021–2025)Chunchang Zhao · East China University of Science and Technology3 papers (2023–2024)Hanrui Chen · Guangzhou University of Chinese Medicine2 papers (2025–2025)Shang Xiang · Guangzhou University of Chinese Medicine2 papers (2025–2025)Jingrong Xian · Sun Yat-sen University2 papers (2022–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Hepatology →